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 The benefits of bloodletting for pneumonia in the nineteenth century were hotly debated. 
 Pneumonia case fatality, recovery times and iron losses are here calculated from available historical data. 
 Early bloodletting and higher iron losses were associated with shorter recovery times, despite higher average case fatality with bloodletting. 
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Abstract 
Objective. To estimate iron losses and disease severity following 19
th
 century bloodletting in patients with pneumonia. 
Study design and setting.  Benefits of bloodletting in pneumonia patients were contested during the 19
th
 century. Although large blood volumes during infection 
were removed there was no systematic data collection assessing efficacy and knowledge of iron composition of blood was rudimentary. This observational 
analysis of historical data quantifies iron losses in pneumonia cases in relation to disease severity. 
Results. Based on one detailed case series average blood volume removed for survivors was 830 ml (range 114 - 2272 ml), and mean recovery times were shorter 
in patients bled within 2 days of illness (p<0.001). Average iron removed was 446 mg with phlebotomy done ≤ 2 days of illness presentation and 347 mg after >2 
days of illness (p=0.012). Across several European hospitals average case fatality in pneumonia patients receiving phlebotomy was higher than in those treated 
without phlebotomy (19.9% vs 12.8%, OR 1.55, 95% CI 1.38-1.74, P<0.001). 
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Conclusion.  Variable efficacy for bloodletting could at least in part be explained by altered iron status.  
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What is New 
 The benefits of bloodletting for pneumonia in the nineteenth century were hotly debated.   
 Pneumonia case fatality, recovery times and iron losses are here calculated from available historical data. 
 Early bloodletting and higher iron losses were associated with shorter recovery times, despite higher average case fatality with bloodletting. 
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For many centuries bloodletting, or the taking of blood from a patient with therapeutic intent, was practised to treat illnesses associated with inflammation and 
fever.
1   
Following the 16
th
 century it was widely used in Western Europe, as it followed Galenic principles by removing excess heat from febrile patients and 
possibly putrid matter.
2
 The Flemish physician Jan Baptist van Helmont (1578-1644), was an iatrochemist who opposed bloodletting in the 17
th
 century. He 
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developed an alternative system of medicine which considered serum as a product of the formation of blood, with disease resulting from an influence on a vital 
principle in the body to which bloodletting would be detrimental.
3, 4
 He proposed a randomised trial to establish if case fatality was reduced from bloodletting by 
treating fever, with or without bloodletting as the standard therapy.
5
 No records are available to confirm whether this experiment was ever undertaken, but its 
theoretical undertones questioned whether phlebotomy impaired vital principles in blood which would otherwise be beneficial to recovery. This early example 
indicated a more scientific approach to understanding how blood constituents reacted during infection. The practice of bloodletting remained the key principle in 
anti-phlogistic therapy for treating fever and inflammation (phlogistos = inflammation) up to the early 19
th
 century.  
Although physicians attested their belief in its value, especially for chest infections, it still lacked an evidence base as efficacy was not addressed until the 
twentieth century. By 1860 knowledge related to blood constituents was increasing and provided insights into the cellular response to infection. Virchow had 
applied Schwann’s concept of the cell to pathology, but only rudimentary laboratory methods for investigation were available, which resulted in a more 
speculative pathology of mechanism.
6, 7 
Large blood volumes blood between one to three litres were often removed within hours of presentation for many 
complaints which included inflammation and fever. Underlying concerns on use of bloodletting were stronger for their rhetoric rather than statistics and have been 
characterised as a clash between established and emerging medical practice.
8
 A theoretical understanding was developing of the potential dangers associated with 
loss of blood nutrients, in particular iron, about which little was known at the time. The action of iron biomarkers in blood and their influence on infection severity 
was potentially enormous. It can be estimated that iron losses with two litres venesection would remove almost 900 mg of body iron, a quarter of the total iron 
content of an average male person.
9 
Repeated bloodletting in pneumonia patients pneumonia would induce hypoferraemia, leading to immune function 
abnormalities and an anti-inflammatory effect by limiting bacterial access in the blood to extracellular iron.
10, 11  
         
6 
 
In this paper 19
th
 century historical data on pneumonia case fatality is analysed to estimate bloodletting efficacy in relation to mortality outcomes and iron deficits 
and potential implications for patient outcomes. 
   
2. Search strategy 
Physical searches for 19
th
 century historical information used library resources, inter-library loan facilities and the Archive collection at the University of 
Liverpool. For recent publications electronic databases were examined for historical and scientific content, including PubMed, Scopus and ISI Web of knowledge, 
using the search terms: bloodletting, venesection, pneumonia, infection and mortality. Reference lists from general medical and historical journals were searched. 
A summary of the debate between the merits of clinical decisions versus the scientific approach to the use of bloodletting in pneumonia current in mid-19
th
 century 
is outlined in supplementary File 1. 
12, 13 
The best pneumonia outcome data came from Pierre-Charles-Alexandre-Louis. In general outcomes were more often 
reported for acute pneumonia than other conditions. 
 
3. Pierre-Charles-Alexandre-Louis and management of pneumonitis by bloodletting 
Questions about bloodletting in chest infections initially arose in 1828 when Pierre-Charles-Alexandre-Louis (1787-1872) published his original findings on the 
efficacy of bloodletting in patients with pneumonitis (pneumonia) treated at the Hôpital de la Charité in Paris. His observations were unique as he selected patients 
who were previously in good health and who had a uniform definition of acute pneumonia which reduced misclassification.
14
 His findings were re-published in 
1835, with further observations from cases under his care admitted to the Hôpital de la Pitié in Paris.
15
 Surviving patients were grouped by the number of times 
phlebotomy was used, illness duration and time of first bleeding and, for La Charité information was provided for patients who died. Figure 1 shows the 
distribution of blood volumes venesected for 101 pneumonia patients listed in his report, both survivors and deaths. Their estimated iron losses in milligrams are 
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derived based on the volumes reported by Louis for an average single bleeding of between 10 and 15 ounces, or 12.5 ounces per bleed (355 mls).
16 
Mean 
phlebotomy volume was around 800 ml. For comparison blood volumes phlebotomy during the last fatal illnesses of President George Washington (1732-1799), 
(2365 mls) and Wolfgang Amadeus Mozart (1756-1791), (1800 mls) are also shown on Figure 1. 
The information available from his published report is summarised in Table 1. Also shown are comparative pneumonia cases treated by phlebotomy in Boston at 
the Massachusetts General Hospital by James Jackson (1777-1867). These cases were reported alongside the original Louis series in the English translation 
published in the United States.
15
 The average blood volume removed for survivors was 830 mls (range 114 to 2485 mls) and the average iron removed (mg) was 
between 347 mg and 446 mg using the same method as above.
16
 Mean phlebotomy volume for patients who died at La Charité Hôpital was greater (1024 mls) than 
that for survivors, which equates to higher loss of body iron. Statistical comparison of these patient classes is suggestive (see footnote p values Table 1) but limited 
due to possible confounding. Sample sizes were small, younger patients were likely to recover more quickly and survivors were younger than case fatalities. Also 
varying proportions of patients were bled within two or four days of their presentation.  
Re-calculation from the original data of mean recovery times (in days) comparing patients bled within two days of illness presentation with those bled after two 
days consistently shows in survivors shorter illness duration with earlier bleeding (Table 1). In cases from La Charité hospital venesection in the first few days was 
associated with higher mortality, and re-analysis of this data by Morabia showed the odds of death were more than halved compared to those bled late. 
17 
Early 
copious bleeding with its associated higher mortality risk might result from more severe disease in some of these cases. Nevertheless, Louis concluded that, while 
pneumonitis was not arrested by bloodletting, those bled during the first four days recovered (other things being equal) four or five days sooner than those bled at a 
later period. His general conclusion was that that ‘bloodletting had no appreciable influence on the progress of the disease’, but this was based mainly on his 
findings in patients with erysipelas and angina tonsillaris. James Jackson attributed the shorter mean duration of illness in his cases at the Massachusetts General 
Hospital (13 days, Table 1) not to early intervention, but to better general care in a smaller hospital with higher ward temperatures than the colder Parisian 
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hospitals. That apart, the clinical profiles of Jackson’s pneumonia cases showed these were, on average, several years younger than Paris cases, which could 
favour recovery. Theoretically there is some justification from the data in Table 1 that the earlier average time of bleeding for the American cases shortened their 
recovery compared to the Parisian series. 
The findings presented by Louis invoked strong professional opposition as they undermined current medical practice and de-emphasised the traditional anti-
phlogistic treatment which bloodletting was thought to provide by correcting imbalances in body secretions. That organised epidemiological enquiries or 
experimental science could govern therapeutic practice had fundamental implications for professional identity. A fundamental problem was the absence of an 
accepted avenue for calling into question the utility of practices such as bloodletting. Lack of knowledge on pathophysiological mechanisms prevented insight into 
the possible effects of loss of normal blood constituents, including red cell iron, on the inflammatory response to infection. The histological appearances of blood 
were yet to be described, its corpuscular nature was still ill-defined, and the haematological and haemorheological consequences on blood viscosity were 
completely unknown.
18
 However, Louis’ report on pneumonia mortality following bloodletting catalysed an imperative to report pneumonia case fatalities, and 
within twenty years publications from Austria, Sweden, Germany, England, Scotland, Holland and France addressed this question. 
 
4. Pneumonia case fatality in European hospital patients treated with and without bloodletting 
During the first two decades after the publication of Louis’ findings further clinical studies became available on case fatality in patients with pneumonia following 
bloodletting. Most had small sample sizes with imprecise clinical details. Overall case fatality and percentage bled were reported, but without case fatality data for 
patients who did or did not receive phlebotomy and no analyses of efficacy based on cases and controls. During the nineteenth century, lack of reliable statistical 
methods precluded measurement of efficacy which, in this context, is the percentage reduction in case fatality in pneumonia in cases treated with phlebotomy 
compared to cases not receiving venesection. An accepted formula for efficacy estimation had not yet been proposed. Greater scientific rigour in data collection 





Blood volumes collected were often unmeasured or unrecorded. The vigour with which phlebotomy was practised differed, being judged by the 
character of the pulse, degree of flushing of the patient, viscosity and appearance of the blood, and onset fainting. Without this rigour, the interpretation of 
pneumonia case fatality reports was often confounded due to differences in case definition, possible misclassification and varied use of drug treatments. 
Nevertheless, the evidence base was increasing and for European hospital cases is summarised in Table 2.  
This compares case fatality of patients with predominantly acute pneumonia, in the period between 1820 and 1859, who were treated with or without phlebotomy 
and for whom treatment group was clearly stated. The table includes the patient deaths reported by Louis, but not those listed by James Jackson at the 
Massachusetts General Hospital, as details were not provided for the four deaths he reported.
8
 Other studies during this period were derived from published 
lectures or identified in French and German textbooks. The 1866 publication by John Hughes Bennett on the restorative treatment of pneumonia included his cases 
from patient reports from the Edinburgh Royal Infirmary between 1839 and 1863.
19
 Fourteen studies were identified in which all pneumonia cases were treated by 
phlebotomy, and eleven in which pneumonia patients only received alternative treatments. These variously included antimonials, tartar emetics, narcotics, 
digitalis, citrates, alcoholic drinks, calomel and saline purges, or nutritive broths, some of which may have been tried in phlebotomy cases. None of these 
investigations used a case control design, as patients who did not receive phlebotomy were mostly studied at a later date after reductions in phlebotomy as standard 
therapy. Age and sex were inconsistently recorded and while some children or adolescents may have been included, patients with chronic symptoms seem to have 
been excluded as, probably, were pregnant women. 
Average case fatality was seven percent higher in patients receiving phlebotomy (risk ratio 1.55, 95% CI 1.38-1.74, P<0.001), which is a percentage reduction in 
case fatality of 35% by avoiding phlebotomy (95% CI 28% - 43%). In his 1866 report, John Hughes Bennett  compared case fatality expressed as percentages for 
several of the investigators referenced in Table 2 with his own data from the Edinburgh Royal Infirmary collected between 1839 and 1865.
19
  He did not summate 
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findings across studies and used death:survivor ratios to conclude that extreme treatment with phlebotomy was attended with a mortality of about one in three 
cases, although with less extreme application this fell to between one in five to one in thirteen. He attributed variations to weakness induced in the patient by 
phlebotomy and associated treatments and noted improved outcomes in children and adolescents. 
Amongst the alternative interventions he used were restorative nutritional treatments which resulted in a mortality ratio of approximately one in 33 cases, and even 
these deaths were reported to be due to complications unconnected with the pneumonia. By improving patient diets Bennett attributed recovery to restoring the 
‘nutritive power of the system’. Although he recommended and prescribed ‘beef tea’ for some pneumonia patients, he neither mentioned iron losses incurred by 
phlebotomy, nor improved iron intakes with recovery, in support of this remedy. His appreciation of the importance of nutritional therapy was considerable and 
although the amount of iron in blood had yet to  be determined he concluded in 1842 that ‘blood circulating to every part of the living organism carried with it the 
principles of nutrition’.
20
 This theme he developed into a nutritional theory explaining the process of inflammation which he later used as the main scientific 
rationale for abandoning phlebotomy in the treatment of infection.
21
 The specific role of iron would not be evident without a clearer understanding of blood 
composition, but by the mid-1850’s, comparative case fatality statistics indicated that removing large volumes of the patient’s blood during pneumonia infection 
was often, although not always, detrimental. In the context of bloodletting the argument centred round the nature of inflammation.  
Although it was recognised by almost all that inflammation involved buffed blood (the top layer of white blood cells on standing) and excess fibrin, no further 
investigations ensued. These changes in febrile cases led Emile Bertin (born 1832) to conclude, in a dictionary of science published in 1878, that bloodletting was 
still relevant as it helped to deplete these factors.
22
 The value of iron compounds in reviving blood was recognised, but only after 1860 was the role of iron in 
blood becoming understood. Prior to then it was linked to apathy, melancholia, anorexia and poor appetite, all of which were often associated with anaemia. 
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5. Haematological and cardio-pulmonary effects of bloodletting 
Anaemia was a confusing issue because the difference between nutritional anaemias such as iron deficiency, and inflammatory anaemia which occurred with 
infection, was unknown. The clinical and functional significance of fewer red cells was unclear without information on the constitution of blood in patients and 
how these characteristics related to disease severity. A more comprehensive clinical picture of anaemia, iron deficiency and the potential effects of blood loss did 
not emerge until the early 20
th
 century. Bloodletting was often used for treatment of fever in plethoric patients, while in those with pallor, although improved 
nutrition was recognised, venesection was still used to remove morbid factors. As a result, the possible effects of bloodletting on body iron were unappreciated and 
potentially beneficial cardio-pulmonary effects with acute venous congestion could not be distinguished. 
The result was a confusing picture. Paradoxically, by the late 19
th
 century, prescribing of iron supplements in patients with a variety of acute and chronic infections 
was frequent.
23   
Figure 2 shows an example promoting use of Iron Bitters, a popular therapy in America and recommended as a cure for intermittent fevers, 
malaria, dyspepsia and weakness. In contrast, although use of bloodletting declined, as late as 1892, the first edition of Sir William Osler’s (1849-1919) textbook 
on the Practice of Medicine recommended moderate venesection (~500 ml) in pneumonia. 
24
 Osler’s recommendation continued through several editions of his 
textbook until 1947 (16th edition) based on venesection to reduce venous pressure in congestive heart failure complicating pneumonia. By the mid-20
th
 century 
Paul Wood (1907-1962), the greatest British cardiologist of his time, commented that although venesection had fallen out of favour, it should not be abandoned 




William Markham commented in his Gulstonian lecture of 1864, that ‘--- never, perhaps, has more blood flowed from the veins and arteries of mankind, under the 
authority of medicine, than during the first quarter of the present century’.
26
 The mid-century decline in its use was fostered by evidence that overall case fatality 
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tended to be higher with venesection, despite Louis’ findings that bloodletting for pneumonia within 2-4 days of presentation lead to shorter recovery times. The 
possibility that blood constituents directly influenced the inflammatory response was only raised by Bennett, who recognised that lower blood volumes altered 
blood constituents. While he did not mention blood iron or body iron losses, he recognised the potential role of ‘molecules’, as well as nutrition, in affecting the 
inflammatory response to infection. A remarkable foresight in this pre-Pasteurian period. 
Opinions on the efficacy of bloodletting in the treatment of pneumonia in the mid-19
th
 century led to conflicts which were poised between the clinical experience 
of early 19
th
 century physicians and scientific insights arising later in the century. Blurring of case definitions, combined with variable use of small, moderate or 
large volume venesection at differing times following presentation, altered risk-benefit ratios. Early bloodletting of moderate volume in patients without cardiac 
complications could have a beneficial effect related to bacterial iron restriction, whereas large volume losses over a longer period could be detrimental due to 
dehydration, poor oxygen saturation, anaemia and lower blood volumes. Experience dictated the importance of bleeding during the early stages of disease before 
overt signs of inflammation were apparent, although the rationale for this remained unclear. Use of comparative observational case fatality statistics with such 
mixed groups of patients inevitably led to unreliable conclusions, although in retrospect the data in Table 2 arguably suggests overall case fatality from 
bloodletting in pneumonia was detrimental. The paradox is, that while rapid removal of iron by moderate bloodletting during acute infection may in certain 
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Figure 1   Phlebotomy volumes and estimated iron losses in Louis’ patients with pneumonia 
Sources: Louis PCA, reference 8; Haskins et al, reference 9; Morens DM. Death of a President. New England Journal of Medicine 1999;341:1845-1850; Drake 
ME. Mozart’s chronic subdural hematoma. Neurology 1993; 43;2400-2403. 




Figure 2 Nineteenth century promotion of iron supplementation for infective illness 
       The text at the side of the desk reads: Brown’s iron bitters has cured the whole family of malaria and as a personal tonic we believe it has no equal. 
Baltimore: Brown Chemical Co. trade card [ca.1880], New York: Burrow Giles Lith; image is in the public domain. 
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Table 1 Summary characteristics of pneumonitis patients and their phlebotomy volumes with resultant iron losses at La Charité  
              and La Pitié Hospitals, Paris and Massachusetts General Hospital, Boston and published in the years 1835 and 1836 
     























estimated iron losses in mgs. 
 
Variable 
                                       Survivors     Deaths
 a
 
 Charité Pitié MGH All     Charité 
Patient profile     
 
Number 49 25 29 103 27 
Mean age, years 35.3 40.8 25.6 33.9 48.8 
Mean day of first bleeding after onset of illness 5.2 5.0 4.2 4.8 4.1 
Mean number of bleedings 2.4 1.8 2.0 2.1 2.8 
Bled within 2 days of disease onset, % 10.2 12.0 44.8 20.4 22.2 
Bled within 4 days of disease onset, % 44.9 52.0 75.9 55.3 66.6 
Mean illness duration, days (SD) 19.3 (7.4) 17.1 (6.2) 13.0 (3.9) 17.1 (6.9) 19.3 (14.3) 
Mean duration if bled within 2 days of disease onset, days SD (n) 11.6 (5) 14.0 (3) 11.6 (13) 11.9 ± 2.7 (21) 
b
 18 ±16.0 (6) 
Mean duration if bled after 2 days of disease onset, days SD (n) 20.2 (44) 17.5 (22) 14.2 (16)   18.3 ± 7.1 (82)   19.7 ± 14.1(21) 
Mean phlebotomy volume, ml (SD) 
c
 859 (325) 749 (266) 851 (539) 830 (390) 1024 (524) 
                                 range, ml 114 - 1775 114 - 1420 227 - 2272 114 - 2272 355 - 2485 
 
Estimated mean iron removed (mg) by phlebotomy 
d 
    
 
Phlebotomy done ≤ 2 days after onset of illness, ± SD (n) 343(5) 342 (3) 510 (13) 446 ± 263 (21) 
e
  599 ± 318 (6) 
f
 
Phlebotomy done after 2 days of disease onset, (n) 382 (43) 328 (22) 277 (16)   347 ± 144 (81)  394 ± 174 (21) 
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a   In addition four deaths at La Pitié: mean age 61 years and mean disease duration of 13 days; 3 bled after 4 days. Also four deaths at MGH with no   
further details available. Phlebotomy volumes not reported for these deaths. 
b   For survivors mean difference in duration by T test between ≤2 days and > 2 days for all hospitals: one-tailed with unequal variance,  
     P < 0.001; one   tailed with equal variance P <0.001. 
       c   Converted from ounces reported in original publication. For La Charité and La Pitié hospitals between 10 – 15 ounces taken at each bleeding and a 
mean of 12.5 ounces (355 ml) used for phlebotomy volume estimates for these hospitals. For La Charité one phlebotomy volume not reported. 
      d    Assumed haematocrits (packed red cell volume) were 40% at baseline. All estimates expressed in terms of mg, iron, using a value of 1.1 mg iron/1.0 ml 
packed red cells. (Haskins et al). 
      e    For survivors mean difference in iron losses by T test between ≤2 days and > 2 days for all hospitals: one-tailed with unequal variance, 
            P = 0.058; one tailed with equal variance P = 0.012. 
      f     For deaths mean difference in iron losses by T test between ≤2 days and > 2 days for La Charité Hospital: one-tailed with unequal variance, P = 0.120; 
one tailed with equal variance P = 0.039. 
 
      Sources: Pierre-Charles-Alexandre-Louis, Researches on the Effects of Bloodletting in some Inflammatory Diseases and on the Influence of Tartarised 
Antimony and Vesication in Pneumonitis. Translated by C.G. Putnam with a Preface and Appendix by James Jackson, Boston: Hilliard Gray and Company, 
1836; D. Haskins, A.R. Stevens Jr, S.C. Finch, C.A. Finch, ‘Iron metabolism. Iron stores in man as measured by phlebotomy’, J Clin Invest 1972; 31:543-47. 
 




Location Pneumonia category Cases Deaths Case 
fatality % 
Patients with phlebotomy 
Enrico Acerbi  (1785-1827)  1 Pre-1820 Milan, Maggiore Hospital All 
b
 142 16 11.1 
René Laennec (1781-1826) 2 Pre-1826 Paris All - - 12.0 -16.0  
William Pulteney Alison (1790-1859) 3 Post-1822  Edinburgh Royal Infirmary All 8 2 25.0 
Jean-Baptiste Bouillard (1796 -1881) 4 1831-1834 Paris, Hôpital de la Charité  All 102 12 11.8 
Gabriel Andral (1797-1876) 5 Pre- 1834 Paris, Hôpital de la Charité Uncomplicated 29 14 48.3 
    Complicated 36 22 61.1 
Pierre-Charles-Louis (1787-1872)  6 1828-1835 Paris, Hôpital de la Charité 









James Jackson (1777-1867) 7 1825-1834 Massachusetts General Hospital All 33 4 12.1 
John Hughes Bennett (1812-1875)  8 1812-1837 Edinburgh Royal Infirmary All 50 19 38.0 
Pierre Briquet (1796 -1881) 9 1836-1839 Paris, Hôpital Cochin All 140 29 20.7 
Jόzef Dietl (1804-1878)  10 Pre-1840
 c
 Vienna, Wieden Hospital  Mostly large bleedings.  
7 uncomplicated cases 
85 17 22.0 
Table 2 Case fatality in hospital patients with pneumonia treated with and without phlebotomy 
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John Hughes Bennett  11 1839-1849 Edinburgh Royal Infirmary All 648 222 34.3 
Magnus von Huss (1807-1890) 12 1840-1847 Stockholm, Seraphim-Lazarethe 
Hospital 
Also with local bleedings. 
Two-thirds uncomplicated 
1040 120 11.5 
Robert Bentley Todd (1809 -1860) 13 1840-1847 London, King’s College Hospital - 25 4 16.0 
Hermann Lebert (1813-1878)  14 1853-1859 Zurich Hospital 4 cases complicated 205 15 7.3 
All investigators      2648 527 19.9 
Patients without phlebotomy 
John Rasori (1767-1823) 15 Pre-1823 Milan, Santa Corona Hospital - 648 143 22.1 


















Jόzef Dietl  17 Pre-1840 
c
 Vienna, Wieden Hospital  Deaths all complicated  295 36 12.2 
John Hughes Bennett  18 1849-1863 Edinburgh Royal Infirmary All 115 3 2.6 
Karl Kissel  19 1852 
e
 Germany, location not specified Iron acetate orally if  
alkaline urine 
112 5 4.5 
Magnus von Huss  20 1848-1855 Stockholm, Seraphim Lazarethe 
Hospital 
Two thirds uncomplicated 
cases 
1576 161 10.2 
Karl Heinrich.Thielmann (1802-1872)  21 Pre-1852 
c




 stage (no deaths) 
32  2
nd
 stage (3 deaths) 
24  3
rd
 stage (8 deaths) 
113 11 9.7 
F.J.J.Schmidt 22 1851-1854 Rotterdam Krankenhuis - 37 4 10.8 
Heinrich von Bamburger (1822-1888)  23 1857 
c
 Wurzburg, Julius Hospital Few leeches applied in 
minority 
186 21 11.3 
Professor Dr Rigler  24 1856-1858 Gratz, General Hospital Venesection in only 4 
cases; leeches in several 
119 20 16.8 
Robert Bentley Todd  
 
25 1847-1859 London, King’s College Hospital - 53 6 11.3 
All investigators      3486 447 12.8 
 
a    
Details of References for sources listed in supplementary file 1. 
b  
 All indicates both uncomplicated and complicated cases 
c
   Uncertain period of enrolment, probably before 1840 
d   










   Date of publication, not date of patient recruitment. 
 
         
